deltatrials
Completed NA INTERVENTIONAL 2-arm NCT00653432

Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee

A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate to Provide Symptomatic Relief of Osteoarthritis of the Knee

Sponsor: Anika Therapeutics, Inc.

Conditions Osteoarthritis
Updated 9 times since 2017 Last updated: Jun 21, 2023 Started: Jan 31, 2008 Primary completion: Dec 31, 2009 Completion: Feb 28, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00653432, this NA trial focuses on Osteoarthritis and remains completed. Sponsored by Anika Therapeutics, Inc., it has been updated 9 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Oct 2020 · 28 months · monthly snapshotCompleted~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotCompleted~Jan 2021 – ~Aug 2023 · 31 months · monthly snapshotCompleted~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Aug 2023 — Jul 2024 [monthly]

    Completed NA

  5. Jan 2021 — Aug 2023 [monthly]

    Completed NA

Show 4 earlier versions
  1. Oct 2020 — Jan 2021 [monthly]

    Completed NA

  2. Jun 2018 — Oct 2020 [monthly]

    Completed NA

  3. Feb 2017 — Jun 2018 [monthly]

    Completed NA

  4. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Anika Therapeutics, Inc.
Data source: Anika Therapeutics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .